193 related articles for article (PubMed ID: 34464480)
1. CD146 is a potential immunotarget for neuroblastoma.
Obu S; Umeda K; Ueno H; Sonoda M; Tasaka K; Ogata H; Kouzuki K; Nodomi S; Saida S; Kato I; Hiramatsu H; Okamoto T; Ogawa E; Okajima H; Morita K; Kamikubo Y; Kawaguchi K; Watanabe K; Iwafuchi H; Yagyu S; Iehara T; Hosoi H; Nakahata T; Adachi S; Uemoto S; Heike T; Takita J
Cancer Sci; 2021 Nov; 112(11):4617-4626. PubMed ID: 34464480
[TBL] [Abstract][Full Text] [Related]
2. CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor.
Nodomi S; Umeda K; Saida S; Kinehara T; Hamabata T; Daifu T; Kato I; Hiramatsu H; Watanabe KI; Kuwahara Y; Iehara T; Adachi S; Konishi E; Nakahata T; Hosoi H; Heike T
Oncogene; 2016 Oct; 35(40):5317-5327. PubMed ID: 27041577
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
Stalin J; Traboulsi W; Vivancos-Stalin L; Nollet M; Joshkon A; Bachelier R; Guillet B; Lacroix R; Foucault-Bertaud A; Leroyer AS; Dignat-George F; Bardin N; Blot-Chabaud M
Int J Cancer; 2020 Sep; 147(6):1666-1679. PubMed ID: 32022257
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Zoni E; Astrologo L; Ng CKY; Piscuoglio S; Melsen J; Grosjean J; Klima I; Chen L; Snaar-Jagalska EB; Flanagan K; van der Pluijm G; Kloen P; Cecchini MG; Kruithof-de Julio M; Thalmann GN
Mol Cancer Res; 2019 May; 17(5):1049-1062. PubMed ID: 30745464
[TBL] [Abstract][Full Text] [Related]
5. Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.
Stalin J; Nollet M; Garigue P; Fernandez S; Vivancos L; Essaadi A; Muller A; Bachelier R; Foucault-Bertaud A; Fugazza L; Leroyer AS; Bardin N; Guillet B; Dignat-George F; Blot-Chabaud M
Oncogene; 2016 Oct; 35(42):5489-5500. PubMed ID: 27065325
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.
Beierle EA; Ma X; Stewart JE; Megison M; Cance WG; Kurenova EV
Mol Carcinog; 2014 Mar; 53(3):230-42. PubMed ID: 23065847
[TBL] [Abstract][Full Text] [Related]
7. Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125(FAK).
Anfosso F; Bardin N; Francès V; Vivier E; Camoin-Jau L; Sampol J; Dignat-George F
J Biol Chem; 1998 Oct; 273(41):26852-6. PubMed ID: 9756930
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
[TBL] [Abstract][Full Text] [Related]
9. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
Karacay B; Sanlioglu S; Griffith TS; Sandler A; Bonthius DJ
Cancer Gene Ther; 2004 Oct; 11(10):681-90. PubMed ID: 15332116
[TBL] [Abstract][Full Text] [Related]
11. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
12. MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.
Kodama T; Marian TA; Lee H; Kodama M; Li J; Parmacek MS; Jenkins NA; Copeland NG; Wei Z
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23625-23635. PubMed ID: 31690663
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.
Wang M; Liu Y; Zou J; Yang R; Xuan F; Wang Y; Gao N; Cui H
Oncotarget; 2015 Apr; 6(11):9517-30. PubMed ID: 25940705
[TBL] [Abstract][Full Text] [Related]
14. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
15. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.
Duong C; Yoshida S; Chen C; Barisone G; Diaz E; Li Y; Beckett L; Chung J; Antony R; Nolta J; Nitin N; Satake N
Pediatr Res; 2017 Sep; 82(3):527-535. PubMed ID: 28419087
[TBL] [Abstract][Full Text] [Related]
16. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells.
Anfosso F; Bardin N; Vivier E; Sabatier F; Sampol J; Dignat-George F
J Biol Chem; 2001 Jan; 276(2):1564-9. PubMed ID: 11036077
[TBL] [Abstract][Full Text] [Related]
17. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
[TBL] [Abstract][Full Text] [Related]
18. CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation.
Jouve N; Bachelier R; Despoix N; Blin MG; Matinzadeh MK; Poitevin S; Aurrand-Lions M; Fallague K; Bardin N; Blot-Chabaud M; Vely F; Dignat-George F; Leroyer AS
Int J Cancer; 2015 Jul; 137(1):50-60. PubMed ID: 25449773
[TBL] [Abstract][Full Text] [Related]
19. CD146, from a melanoma cell adhesion molecule to a signaling receptor.
Wang Z; Xu Q; Zhang N; Du X; Xu G; Yan X
Signal Transduct Target Ther; 2020 Aug; 5(1):148. PubMed ID: 32782280
[TBL] [Abstract][Full Text] [Related]
20. Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.
Richards KN; Zweidler-McKay PA; Van Roy N; Speleman F; Trevino J; Zage PE; Hughes DP
Cancer; 2010 Jul; 116(13):3233-43. PubMed ID: 20564646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
